NIST and NCI to collaborate on proteomics assessment

The National Institute of Standards and Technology (NIST) and the National Cancer Institute (NCI) of the National Institutes of Health have begun a program to develop measurement assessment materials needed to evaluate and assess advanced proteomic technologies, such as mass spectrometry, that will play a large role in the discovery and validation of cancer-related proteins found in readily accessible body fluids.

The discovery that the appearance of specific proteins (or changes in the structure or concentration of a protein) in body fluids could be associated with the presence of particular cancers goes back to the 19th century, but actually identifying and validating these proteins has been difficult. Humans are estimated to have roughly 400,000 different proteins, with the specifics constantly changing with age, health and environment. In the 159 years since the discovery of the first protein cancer biomarker, only nine proteins have been approved by the Food and Drug Administration as diagnostic markers for cancer.

The rapidly developing field of proteomics--the large-scale study of proteins and their interactions through methods such as multidimensional separations, mass spectrometry and protein arrays--could significantly advance the search for novel cancer-related proteins. However, there is a shortage of rigorous measurement quality assurance tools for proteomics to ensure reliable and reproducible research results. NCI has begun a $104 million, 5-year program called the Clinical Proteomic Technology Initiative for Cancer (http://proteomics.cancer.gov) to refine and standardize proteomic technologies, reagents and methods to establish the measurement technology needed to validate protein discoveries and move these technologies into a clinical setting.

Under an agreement finalized on May 5, NIST will develop a measurement assessment material composed of proteins mimicking the complexity an

Contact: Michael Baum
National Institute of Standards and Technology (NIST)

Page: 1 2

Related biology news :

1. K-State to collaborate on research to forecast ecological consequences of environmental changes
2. UT Metroplex institutions to collaborate on biomedical research
3. Pacific Rim researchers to collaborate on distributed bioinformatics analysis of avian flu
4. Universities collaborate to look at offshore wind power
5. University and health science center in San Antonio collaborate to find chlamydia vaccine
6. Worcester Polytechnic Institute, CellThera collaborate on work aimed at regenerating limbs
7. ORNL, protein discovery researchers collaborate on high-profile paper
8. Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine
9. Universities collaborate to to reduce development impact on the James River
10. UCLA engineering and Mattel Childrens Hospital collaborate to develop childrens heart valve
11. Roche and SystemsX collaborate in diabetes research

Post Your Comments:

(Date:10/17/2019)... HOUSTON, Texas (PRWEB) , ... October 15, 2019 ... ... engineering firm, is pleased to announce it made its first appearance on the ... two-year revenue growth of 56 percent. , With corporate headquarters in Houston, ...
(Date:10/17/2019)... NEW YORK (PRWEB) , ... October 16, 2019 ... ... together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its ... Apella by Alexandria in New York, NY. , The event ...
(Date:10/15/2019)... ... October 14, 2019 , ... Erchonia, the ... announces its upcoming Business Meeting in Orlando & 18th Annual Golf Tournament. ... Orlando, near Erchonia’s headquarters in Melbourne. , The first day will kick off ...
Breaking Biology News(10 mins):
(Date:10/17/2019)... ... October 15, 2019 , ... TopConsumerReviews.com recently gave their top ... for health and/or genealogy research purposes. , There are many reasons why has ... to know more about themselves at a cellular level: family history, predisposition towards ...
(Date:10/10/2019)... ... October 09, 2019 , ... The International Society ... FDA, as a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting ... , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized ...
(Date:10/10/2019)... ... October 10, 2019 , ... VirTrial ... research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial ... and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell ... lead development technology. Like the company’s precursor patent, approved in the U.S. in ... of tissue stem cells. Asymmetrex now markets the technology in the U.S. as ...
Breaking Biology Technology:
Cached News: